Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Products targeted to aid specific activities throughout day: Rise, Compete, Recover, SleepPHAZE offered in topicals, gum, tinctures and topical patches North Providence, RI, Dec. 02, 2021 ...
-
PINE BLUFF, Ark., Dec. 02, 2021 (GLOBE NEWSWIRE) -- On November 19, 2021, Simmons First National Corporation (NASDAQ: SFNC) (“Simmons” or “Company”) and Spirit of Texas Bancshares, Inc. (NASDAQ:...
-
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave” ("EnWave"), announced that Dairy Concepts IRL (“DCI”), an emerging leader in...
-
SEATTLE, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
-
UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of...
-
UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of...
-
Pune, India, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The global graphite market size was USD 13.60 billion in 2020. Based on our analysis, the market is projected to grow from USD 14.83 billion in 2021 to...
-
Pune, India, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The global inertial navigation system market size is projected to grow from USD 10.59 billion in 2021 to reach USD 15.45 billion by 2028 and exhibit a...
-
Anticipate First Patient Dosing in Phase 1/2 Clinical Trial for XTX202, a Tumor-Selective IL-2, in First Quarter of 2022 Advancing Phase 1/2 Clinical Trial for XTX101, a Tumor-Selective Anti-CTLA-4...
-
NEW YORK and LEAMINGTON, Ontario, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution,...